ResearcherFujian Medical UniversityActive in the last 2 years
Wei J. Wang
Matched on ORCID iD 0000-0002-4848-7394; OpenAlex author ID A5115695500. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 2 papers
Papers 3
- Targeting CA9 restricts pancreatic cancer progression through pH regulation and ROS production. Co-author DOI 10.1007/s13402-024-01022-9↗
- Integration of single-nucleus and exosome RNA sequencing dissected inter-cellular communication and biomarkers in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.csbj.2024.04.021↗
- Echinacoside suppresses pancreatic adenocarcinoma cell growth by inducing apoptosis via the mitogen-activated protein kinase pathway. Co-author DOI 10.3892/mmr.2016.4867↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jin Xu · 2 shared papers, 2024 · strength 0.45
- Xianjun Yu · 2 shared papers, 2024 · strength 0.45
- Si Shi · 2 shared papers, 2024 · strength 0.45
- Xuhui Tong · 1 shared paper, 2024 · strength 0.26
- H. J. Yang · 1 shared paper, 2024 · strength 0.26
- Qingcai Meng · 1 shared paper, 2024 · strength 0.20
- Rong Tang · 1 shared paper, 2024 · strength 0.20
- Jie Hua · 1 shared paper, 2024 · strength 0.20
- Bo Zhang · 1 shared paper, 2024 · strength 0.20
- Chen Liang · 1 shared paper, 2024 · strength 0.20
- Qiong Du · 1 shared paper, 2024 · strength 0.20
- Yuan Liu · 1 shared paper, 2024 · strength 0.20
- Xinfeng Li · 1 shared paper, 2016 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.